3535-35-1 Usage
Uses
Used in Pharmaceutical Industry:
4-ISOBUTOXY-3-METHOXY-BENZOIC ACID is used as an intermediate in the synthesis of various pharmaceuticals for its ability to be incorporated into complex molecular structures, contributing to the development of new drugs.
Used in Agrochemical Industry:
4-ISOBUTOXY-3-METHOXY-BENZOIC ACID is utilized as an intermediate in the production of agrochemicals, where its chemical properties can be leveraged to create effective pesticides or other agricultural products.
Used in Polymer Production:
4-ISOBUTOXY-3-METHOXY-BENZOIC ACID is used in the manufacturing of polymers, where its chemical structure can influence the polymer's properties, such as strength, flexibility, or stability.
Used in Industrial Chemicals Production:
4-ISOBUTOXY-3-METHOXY-BENZOIC ACID is also used in the production of other industrial chemicals, where its versatile properties can be applied to create a range of different chemical products.
Used in Therapeutic Applications:
4-ISOBUTOXY-3-METHOXY-BENZOIC ACID is used as a potential therapeutic agent for its anti-inflammatory and analgesic properties, making it a candidate for the treatment of various conditions that involve inflammation and pain.
Check Digit Verification of cas no
The CAS Registry Mumber 3535-35-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,3 and 5 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3535-35:
(6*3)+(5*5)+(4*3)+(3*5)+(2*3)+(1*5)=81
81 % 10 = 1
So 3535-35-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H16O4/c1-8(2)7-16-10-5-4-9(12(13)14)6-11(10)15-3/h4-6,8H,7H2,1-3H3,(H,13,14)
3535-35-1Relevant academic research and scientific papers
Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu7 Negative Allosteric Modulator (NAM) in Vivo Tool Compound: N-(2-(1 H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962)
Reed, Carson W.,Yohn, Samantha E.,Washecheck, Jordan P.,Roenfanz, Hanna F.,Quitalig, Marc C.,Luscombe, Vincent B.,Jenkins, Matthew T.,Rodriguez, Alice L.,Engers, Darren W.,Blobaum, Anna L.,Conn, P. Jeffrey,Niswender, Colleen M.,Lindsley, Craig W.
supporting information, p. 1690 - 1695 (2019/02/24)
Herein, we report the discovery of a new, orally bioavailable and CNS-penetrant metabotropic glutamate receptor 7 (mGlu7) negative allosteric modulator (NAM) that achieves exposure in cerebral spinal fluid (CSF) 2.5× above the in vitro IC50 at minimum effective doses (MEDs) of 3 mg/kg in preclinical anxiety models.
2-isobuoxy-5 - (4- isobutyl phenyl ether ketone ) phenoxy acid compound preparation and use thereof
-
Paragraph 0034; 0040-0042, (2017/04/06)
The invention provides a 2-isobutoxy-5-(4-isobutoxybenzophenone)phenoxyacetic acid compound which has a structure represented by formula I as described in the specification. The compound has an excellent inhibitory effect on survival and growth of superbacteria.
